Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-584673
Filing Date
2016-05-10
Accepted
2016-05-10 07:08:56
Documents
48
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d183124d10q.htm 10-Q 289621
2 EX-10.1 d183124dex101.htm EX-10.1 23844
3 EX-31.1 d183124dex311.htm EX-31.1 7101
4 EX-31.2 d183124dex312.htm EX-31.2 7096
5 EX-32.1 d183124dex321.htm EX-32.1 3927
6 EX-32.2 d183124dex322.htm EX-32.2 3908
  Complete submission text file 0001193125-16-584673.txt   2017540

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tkai-20160331.xml EX-101.INS 337119
8 XBRL TAXONOMY EXTENSION SCHEMA tkai-20160331.xsd EX-101.SCH 29843
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tkai-20160331_cal.xml EX-101.CAL 39715
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tkai-20160331_def.xml EX-101.DEF 74091
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tkai-20160331_lab.xml EX-101.LAB 213848
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tkai-20160331_pre.xml EX-101.PRE 145721
Mailing Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 161633653
SIC: 2834 Pharmaceutical Preparations